We Have Ways To Stop Rogue Scientists. They Don’t Always Work.
By Maggie Koerth-Baker,
FiveThirtyEight
| 12. 10. 2018
How do you stop a mad scientist?
We’ve been doing it in fiction for centuries. Doctor Faustus was carried off to hell. Pneumonia and an Arctic ice flow ended Victor Frankenstein. Doctor Moreau’s own creations ultimately did him in, which is a more poetic way of saying that he ended up on the wrong end of a fight with a puma-woman.
But all of these fictional comeuppances are proxies for our frustration with science’s potentially unchecked power. Lacking the devil, or a deus ex machina, us nonfictional people are still faced with the challenge of stopping rogue researchers. So can the public control science that leaves us with permanent and unenviable consequences? Recent news suggests that the answer is “not really.” There are tools that we can use to place limits on scientists and the choices they make. But none of them can fully, reliably, put the public in the driver’s seat. And maybe that’s OK.
The mad scientists of the past — both the imaginary and the all too real — have been on my mind. On...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...